US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 48.240
  • +1.840+3.97%
Close Nov 22 16:00 ET
1.84BMarket Cap-12864P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tarsus Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
43.18M
48.12M
+4.94M
Beat Est.
+2207.68%
+2471.78%
+11.44%
EPS
-0.92
-0.61
+0.31
Beat Est.
+28.46%
+52.34%
+33.38%
Analyst Rating
Strong Buy

Nov 24, 2024

Tarsus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 62.472M--
--2024/Q4-- / 57.116M--
Nov 13, 20242024/Q348.118M / 43.177M--
Aug 8, 20242024/Q240.813M / 32.048M--
May 8, 20242024/Q127.614M / 17.898M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 62.472M--
--2024/Q4-- / 57.116M--
Nov 13, 20242024/Q348.118M / 43.177M--
Aug 8, 20242024/Q240.813M / 32.048M--
May 8, 20242024/Q127.614M / 17.898M--

Unlock Free Earnings Estimates

Tarsus Pharmaceuticals Earnings Reports

  • Tarsus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 14 05:18

  • Tarsus Pharmaceuticals | 8-K: Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

    Nov 14 05:12

  • Tarsus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:21

  • Tarsus Pharmaceuticals | 8-K: Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

    Aug 9 04:10

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 24, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data